1
|
Jodłowski PJ, Dymek K, Kurowski G, Hyjek K, Boguszewska-Czubara A, Budzyńska B, Mrozek W, Skoczylas N, Kuterasiński Ł, Piskorz W, Białoruski M, Jędrzejczyk RJ, Jeleń P, Sitarz M. Crystal Clear: Metal-Organic Frameworks Pioneering the Path to Future Drug Detox. ACS APPLIED MATERIALS & INTERFACES 2024. [PMID: 38815127 DOI: 10.1021/acsami.4c02450] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2024]
Abstract
The growing number of acute drug abuse overdoses demands the development of innovative detoxification strategies for emergency purposes. In this study, an innovative approach for the application of porous Zr-based metal-organic frameworks for the treatment of acute overdoses of popular drugs of abuse including amphetamine, methamphetamine, cocaine, and MDMA is presented. A comprehensive approach determining the efficacy and the kinetics of drug removal, considering dosage, adsorption time, and adsorption mechanisms, was tested and corroborated with density functional theory (DFT) modeling. The experimental results showed high removal efficiency reaching up to 90% in the case of the application of the NU-1000 metal-organic framework. The difference Raman spectroscopy method presented in this study corroborated with DFT-based vibrational analysis allows the detection of drug adsorbed in the MOF framework even with as low a concentration as 5 mg/g. Additionally, the drug adsorption mechanisms were modeled with DFT, showing the π-π stacking in a vast majority of considered cases. The performance and influence on the living organisms were evaluated throughout the in vitro and in vivo experiments, indicating that Zr-based MOFs could serve as efficient, organic, safe drug adsorbents.
Collapse
Affiliation(s)
- Przemysław J Jodłowski
- Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, Kraków 31-155, Poland
| | - Klaudia Dymek
- Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, Kraków 31-155, Poland
- Lukasiewicz Research Network - Krakow Institute of Technology, Zakopiańska 73, Kraków 30-418, Poland
| | - Grzegorz Kurowski
- Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, Kraków 31-155, Poland
| | - Kornelia Hyjek
- Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, Kraków 31-155, Poland
| | - Anna Boguszewska-Czubara
- Department of Medical Chemistry, Medical University of Lublin, Chodzki 4A, Lublin 20-093, Poland
| | - Barbara Budzyńska
- Independent Laboratory of Behavioral Studies, Medical University of Lublin, Chodzki 4A, Lublin 20-093, Poland
| | - Weronika Mrozek
- Independent Laboratory of Behavioral Studies, Medical University of Lublin, Chodzki 4A, Lublin 20-093, Poland
| | - Norbert Skoczylas
- Faculty of Geology, Geophysics and Environmental Protection, AGH University of Krakow, Mickiewicza 30, Kraków 30-059, Poland
| | - Łukasz Kuterasiński
- Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Niezapominajek 8, Kraków 30-239, Poland
| | - Witold Piskorz
- Faculty of Chemistry, Jagiellonian University in Kraków, Gronostajowa 2, Kraków 30-387, Poland
| | - Marek Białoruski
- Faculty of Chemistry, Jagiellonian University in Kraków, Gronostajowa 2, Kraków 30-387, Poland
| | - Roman J Jędrzejczyk
- Małopolska Centre of Biotechnology, Jagiellonian University in Kraków, Gronostajowa 7A, Kraków 30-387, Poland
| | - Piotr Jeleń
- Faculty of Materials Science and Ceramics, AGH University of Krakow, Mickiewicza 30, Kraków 30-059, Poland
| | - Maciej Sitarz
- Faculty of Materials Science and Ceramics, AGH University of Krakow, Mickiewicza 30, Kraków 30-059, Poland
| |
Collapse
|
2
|
Hrin ML, Huang WW. Sweet Syndrome and Neutrophilic Dermatosis of the Dorsal Hands. Dermatol Clin 2024; 42:193-207. [PMID: 38423681 DOI: 10.1016/j.det.2023.08.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/02/2024]
Abstract
Sweet syndrome is a rare cutaneous condition with a broad clinical differential diagnosis. It can be classified into 3 subtypes: classic, malignancy-associated, and drug-induced. There are numerous associated disorders and provoking medications. Uncommonly, it can present as a multiorgan disease and cause significant morbidity. Systemic corticosteroids are the gold standard of treatment and yield rapid improvements in both lesions and symptoms. Nonsteroidal therapies may be effective alternatives, although high-quality comparative data are lacking. Some treatments for Sweet syndrome have paradoxically been implicated in the induction of disease.
Collapse
Affiliation(s)
- Matthew L Hrin
- Department of Dermatology, Wake Forest School of Medicine, Medical Center Boulevard, 4618 Country Club Road, Winston-Salem, NC 27157-1071, USA.
| | - William W Huang
- Department of Dermatology, Wake Forest School of Medicine, 4618 Country Club Road, Winston-Salem, NC 27104, USA
| |
Collapse
|
3
|
Viedma-Martinez M, Gallo-Pineda G, Recio-Monescillo M, Jimenez-Gallo D, Lopez-Sanz P, Drake-Monfort M, Urigoitia-Ugalde P, Martínez-Signes V, Llorca-Juan D, Fuertes-Vega L, Ríos-Viñuela E, Escario-Travesedo E, Ríos-Martín JJ, Requena-Caballero L, Linares-Barrios M. Retrospective Case Series of Cocaine-Associated Plasma Cell Orificial Mucositis. JAMA Dermatol 2024; 160:320-327. [PMID: 38265770 PMCID: PMC10809139 DOI: 10.1001/jamadermatol.2023.5692] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2023] [Accepted: 11/15/2023] [Indexed: 01/25/2024]
Abstract
Importance Plasma cell orificial mucositis (PCOM) associated with cocaine use is an emerging, rare condition that has become a concern in Spain in recent years. Limited knowledge exists regarding this novel condition. Objectives To delineate the clinicopathologic characteristics of this emerging entity and establish a novel approach in the differential diagnosis of cocaine-associated lesions. Design, Setting, and Participants A descriptive, retrospective, multicenter case series of 10 patients diagnosed with cocaine-associated PCOM was conducted in Spain from April 2020 to March 2023. Main Outcomes and Measures Patient demographic, clinical, histopathologic, and treatment data were collected. Results A total of 10 patients (6 [60%] male; median [range] age, 45.5 [36-66] years) presenting with exudative ulcerated plaques were identified for this study. The lesions had raised and erythematous edges over the nostril and a median (range) evolution time of 9 (2-24) months. Septal or palate perforations were observed in 4 (40%) of the patients. Biopsies revealed a dense inflammatory infiltrate of plasma cells in the dermis without atypia and with eosinophils. All patients reported recent cocaine use. Three urine tests detected cocaine but found no presence of amphetamines or opiates. Six patients improved with corticosteroid therapy. Up to 60% of patients were lost to follow-up. Conclusions and Relevance This case series describes the clinicopathologic characteristics of PCOM, an emerging entity associated with cocaine use in Spain, and demonstrates a novel approach in the differential diagnosis of cocaine-associated lesions. To date, cocaine-associated skin lesions have been reported as neutrophilic dermatoses and vasculitis. The appearance of a plasma cell infiltrate changes what has been described in the medical literature so far. PCOM is a benign condition of unknown cause characterized by a proliferative polyclonal plasma cell infiltrate. A comprehensive differential diagnosis workup is required to reach this exclusionary diagnosis. Several irritants have been documented in cases of PCOM, and a hypersensitivity mechanism has been proposed. Since the initial report of cocaine-associated PCOM in Spain, its incidence has experienced a surge in the country. The cause of this phenomenon may be attributed to newly unidentified adulterants. The administration of corticosteroids and discontinuation of cocaine use are the sole treatments that have demonstrated efficacy. Clinicians should be vigilant regarding this emerging condition and conduct inquiries into cocaine use. Additional research is required to clarify the pathophysiology of this emerging condition.
Collapse
Affiliation(s)
- Myriam Viedma-Martinez
- Department of Dermatology, Hospital Universitario Puerta del Mar, Cádiz, Andalucía, Spain
| | - Gonzalo Gallo-Pineda
- Department of Dermatology, Hospital Universitario Puerta del Mar, Cádiz, Andalucía, Spain
| | - Miguel Recio-Monescillo
- Department of Dermatology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Madrid, Spain
| | - David Jimenez-Gallo
- Department of Dermatology, Hospital Universitario Puerta del Mar, Cádiz, Andalucía, Spain
| | - Pablo Lopez-Sanz
- Department of Dermatology, Hospital General Universitario De Albacete, Albacete, Castilla La Mancha, Spain
| | - Marta Drake-Monfort
- Department of Dermatology, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
| | | | | | - David Llorca-Juan
- Department of Dermatology, Hospital Universitario De La Ribera, Alzira, Valencia, Spain
| | - Laura Fuertes-Vega
- Department of Dermatology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Madrid, Spain
| | - Elisa Ríos-Viñuela
- Department of Dermatology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Madrid, Spain
| | - Eduardo Escario-Travesedo
- Department of Dermatology, Hospital General Universitario De Albacete, Albacete, Castilla La Mancha, Spain
| | - Juan José Ríos-Martín
- Pathology Department, Hospital Universitario Virgen Macarena, Sevilla, Andalucía, Spain
| | - Luis Requena-Caballero
- Department of Dermatology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Madrid, Spain
| | - Mario Linares-Barrios
- Department of Dermatology, Hospital Universitario Puerta del Mar, Cádiz, Andalucía, Spain
| |
Collapse
|
4
|
Sánchez-Puigdollers A, Just-Sarobé M, Pastor-Jané L. Cutaneous and Mucosal Conditions Associated With Cocaine Use. ACTAS DERMO-SIFILIOGRAFICAS 2023; 114:125-131. [PMID: 36115385 DOI: 10.1016/j.ad.2022.09.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2022] [Revised: 08/25/2022] [Accepted: 09/04/2022] [Indexed: 02/06/2023] Open
Abstract
Cocaine and some of its main adulterants, such as levamisole, can cause multiple cutaneous and mucosal manifestations, including ischemic complications, neutrophilic dermatoses, midline destructive lesions, and vasculitis associated with antineutrophil cytoplasmic antibodies (ANCAs). Striking systemic symptoms are generally not seen. In all these conditions, positive test results may be observed for antinuclear antibodies, antiphospholipid antibodies, and various ANCAs, sometimes with characteristic staining patterns. Histology typically shows vascular changes, such as leukocytoclastic vasculitis, necrotizing vasculitis, and thrombi. We review the clinical, serologic, and histologic features of cutaneous and mucosal conditions associated with the use of cocaine and also look at pathophysiologic mechanisms, differential diagnoses, and treatments.
Collapse
Affiliation(s)
| | - M Just-Sarobé
- Servicio de Dermatología, Hospital Universitari Joan XXIII, Tarragona, España
| | - L Pastor-Jané
- Servicio de Dermatología, Hospital Universitari Joan XXIII, Tarragona, España
| |
Collapse
|
5
|
Sánchez-Puigdollers A, Just-Sarobé M, Pastor-Jané L. [Translated article] Cutaneous and Mucosal Conditions Associated With Cocaine Use. ACTAS DERMO-SIFILIOGRAFICAS 2023; 114:T125-T131. [PMID: 36470395 DOI: 10.1016/j.ad.2022.09.018] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2022] [Accepted: 09/04/2022] [Indexed: 12/12/2022] Open
Abstract
Cocaine and some of its main adulterants, such as levamisole, can cause multiple cutaneous and mucosal manifestations, including ischemic complications, neutrophilic dermatoses, midline destructive lesions, and vasculitis associated with antineutrophil cytoplasmic antibodies (ANCAs). Striking systemic symptoms are generally not seen. In all these conditions, positive test results may be observed for antinuclear antibodies, antiphospholipid antibodies, and various ANCAs, sometimes with characteristic staining patterns. Histology typically shows vascular changes, such as leukocytoclastic vasculitis, necrotizing vasculitis, and thrombi. We review the clinical, serologic, and histologic features of cutaneous and mucosal conditions associated with the use of cocaine and also look at pathophysiologic mechanisms, differential diagnoses, and treatments.
Collapse
Affiliation(s)
| | - M Just-Sarobé
- Servicio de Dermatología, Hospital Universitari Joan XXIII, Tarragona, Spain
| | - L Pastor-Jané
- Servicio de Dermatología, Hospital Universitari Joan XXIII, Tarragona, Spain
| |
Collapse
|